Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FHMHU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency for the supply of Stelara 90 mg/ml syringes. The award, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Stelara is a biologic immunosuppressant medication used to treat autoimmune conditions, and its procurement through this delivery order supports the Department of Defense's pharmaceutical supply chain serving military healthcare systems. DMS Pharmaceutical Group has established itself as a critical supplier to federal agencies through consistent contract performance across an extensive portfolio of branded and generic prescription drugs, biologics, vaccines, and specialty medications. The company's federal contracting experience and woman-owned small business status have enabled it to compete effectively in federal procurement markets while maintaining strategic positioning within the DoD pharmaceutical supply network.
Quick answers
Who was awarded contract SPE2DB25FHMHU?
SPE2DB25FHMHU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FHMHU worth?
The government has obligated $48,750 on SPE2DB25FHMHU.
Is contract SPE2DB25FHMHU an order under another contract?
Yes. SPE2DB25FHMHU is a delivery order under SPE2DB24D9245, an indefinite delivery contract.
Was contract SPE2DB25FHMHU competed?
The extent of competition for SPE2DB25FHMHU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award